Savant Capital LLC Makes New $164,000 Investment in Nu Skin Enterprises, Inc. $NUS

Savant Capital LLC acquired a new stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 20,520 shares of the company’s stock, valued at approximately $164,000.

Other hedge funds also recently made changes to their positions in the company. Atlantic Union Bankshares Corp purchased a new position in Nu Skin Enterprises in the second quarter worth $25,000. Virtu Financial LLC bought a new stake in Nu Skin Enterprises during the first quarter worth about $73,000. Harbor Capital Advisors Inc. boosted its holdings in shares of Nu Skin Enterprises by 37.3% in the 2nd quarter. Harbor Capital Advisors Inc. now owns 12,517 shares of the company’s stock worth $100,000 after purchasing an additional 3,400 shares in the last quarter. Russell Investments Group Ltd. increased its position in shares of Nu Skin Enterprises by 41.8% during the 1st quarter. Russell Investments Group Ltd. now owns 17,226 shares of the company’s stock valued at $125,000 after purchasing an additional 5,080 shares during the last quarter. Finally, Amundi increased its position in shares of Nu Skin Enterprises by 18.8% during the 1st quarter. Amundi now owns 18,564 shares of the company’s stock valued at $127,000 after purchasing an additional 2,941 shares during the last quarter. 82.84% of the stock is owned by institutional investors.

Nu Skin Enterprises Price Performance

Shares of Nu Skin Enterprises stock opened at $9.48 on Friday. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.01 and a quick ratio of 1.38. Nu Skin Enterprises, Inc. has a one year low of $5.32 and a one year high of $14.62. The business’s 50 day simple moving average is $10.96 and its two-hundred day simple moving average is $9.68. The stock has a market capitalization of $461.91 million, a P/E ratio of 4.71 and a beta of 0.97.

Nu Skin Enterprises (NYSE:NUS) last issued its earnings results on Thursday, November 6th. The company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.30 by $0.04. Nu Skin Enterprises had a net margin of 6.20% and a return on equity of 8.23%. The firm had revenue of $364.21 million for the quarter, compared to analysts’ expectations of $374.20 million. Nu Skin Enterprises has set its FY 2025 guidance at 1.250-1.350 EPS. Q4 2025 guidance at 0.250-0.350 EPS. Analysts forecast that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current year.

Nu Skin Enterprises Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 10th. Shareholders of record on Friday, November 28th will be given a $0.06 dividend. The ex-dividend date is Friday, November 28th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 2.5%. Nu Skin Enterprises’s payout ratio is presently 11.01%.

Insider Activity

In other Nu Skin Enterprises news, EVP Chayce David Clark sold 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $11.97, for a total transaction of $239,400.00. Following the completion of the transaction, the executive vice president owned 233,140 shares of the company’s stock, valued at $2,790,685.80. This represents a 7.90% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Laura Nathanson sold 6,489 shares of the stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $12.22, for a total value of $79,295.58. Following the completion of the sale, the director owned 33,149 shares of the company’s stock, valued at approximately $405,080.78. This trade represents a 16.37% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 58,926 shares of company stock valued at $711,364. Insiders own 2.00% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on NUS. Weiss Ratings restated a “hold (c)” rating on shares of Nu Skin Enterprises in a research report on Wednesday, October 8th. Zacks Research upgraded shares of Nu Skin Enterprises to a “hold” rating in a report on Tuesday, August 12th. Finally, Wall Street Zen cut shares of Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research note on Saturday, November 15th. Three investment analysts have rated the stock with a Hold rating, According to data from MarketBeat, Nu Skin Enterprises has a consensus rating of “Hold” and an average target price of $7.00.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.